JM
John P McDaniel
Director

John P McDaniel insider trades: Medifast (MED) stock buys and sales

Director, Medifast Last trade Jun 4, 2015 42 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
15
Open-market trades
since 2006
3
Companies
last trade 2015

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where John reports to the SEC

Open-market buys and sales

15 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 4, 2015MED↓ Sell$96K
Jun 4, 2015WRE↓ Sell$48K
Jun 10, 2014MED↓ Sell$111K
Dec 17, 2013WRE↓ Sell$44K
Nov 18, 2013MED↓ Sell$129K
Aug 3, 2012MED↓ Sell$207K
Mar 25, 2010FMAR↓ Sell$23K
Jun 12, 2009WRE↑ Buy$22K
Jun 3, 2009FMAR↑ Buy$25K
Dec 19, 2008FMAR↑ Buy$9K
Nov 21, 2007FMAR↑ Buy$40K
Sep 26, 2007FMAR↑ Buy$27K
Aug 14, 2006WRE↓ Sell$234K
Aug 10, 2006WRE↓ Sell$91K
May 9, 2006FMAR↑ Buy$10K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MED insiders

Open-market trades in the last 12 months

About John P McDaniel's insider trades

John P McDaniel is a director at Medifast (MED). Since May 9, 2006, John has reported 6 open-market purchases worth $133K and 9 sales worth $983K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (29 filings), option exercises (2 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MED insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.